US21900C3088
US21900C3088
CorMedix Inc.
Loading chart...
Pure Price Volatility Risk (Market Swings)
The business itself is financially solid (Financial Health 100/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±76.5% p.a.) and steep historical drawdowns.
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves approx. 1.4x as much as the broader market.
Beta (Market Relation)
1.41x
Above averageVolatility (5Y p.a.)
76.5% p.a.
5-Year HorizonMax Drawdown (5Y)
-62.6%
5-Year HorizonSharpe Ratio
0.08
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
High Volatility
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | -35% |
| 3 Years | 73.1% | -62.3% | 0.34 | +27.6% |
| 5 Years | 76.5% | -62.6% | 0.08 | +8.5% |
| 10 Years | 91.4% | -94.2% | -0.1 | -6.6% |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (76.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -94.2% in the extended horizon.
Corporate Governance & ISS Scores
Overall Governance Risk
6 ISS Score: 6 / 10
Audit Risk
9 ISS Score: 9 / 10
Board Risk
6 ISS Score: 6 / 10
Short Ratio
15.06